Labcorp (NYSE: LH) reported Q2 EPS of $4.96, $0.26 better than the analyst estimate of $4.70. Revenue for the quarter came in at $3.7 billion versus the consensus estimate of $3.75 billion.

GUIDANCE:

Labcorp sees FY2022 EPS of $19.00-$21.25, versus the consensus of $19.70.

For earnings history and earnings-related data on Labcorp (LH) click here.